Abstract

INDICATION OF ORAL ANTICOAGULANTS IN VENOUS THROMBO EMBOLISM

Babitha M.*, Soumya R. V., Jisha Vijayan, Sruthy S. A., Neethu J. and Nithin Manohar R.

Abstract

Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a common, lethal disorder that affects hospitalized and non-hospitalized patients, recurs frequently, is often overlooked, and results in longterm complications including chronic thromboembolic pulmonary hypertension (CTPH) and the post-thrombotic syndrome (PTS). Venous thromboembolism, comprising deep vein thrombosis and pulmonary embolism, is one of the leading causes of mortality and morbidity. Venous thromboembolism is the third most common illness after acute coronary syndrome and stroke. DVTs are most common in adults over age 60. Evidence supports the use of heparin in surgical patients whom have a high risk of thrombosis to reduce the risk of DVTs.

Keywords: Venous thromboembolism (VTE) risk of DVTs.